Distilling new insights from a recent podcast with an industry investor from Nordic Capital, ArisGlobal CEO Aman Wasan makes a robust financial case for advanced automation in processing pharma’s multiplying regulatory and safety workloads.
Infex Therapeutics, an anti-infectives specialist, has announced that in collaboration with Justus-Liebig-University Giessen, it has been awarded a £1 million grant from PACE, to develop a BamA inhibitor.
Betacom has announced a partnership with Siemens Industries. The companies have deployed a private 5G network platform at MxD (Manufacturing x Digital), the National Center for Cybersecurity in Manufacturing in Chicago.
Arriello’s Kate Coleman reviews the findings of new transatlantic research which charts biotechs’ evolving commercialisation strategies and regulatory preparations, and the realities they are experiencing.
Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell cultivation processes in the pharmaceutical industries.
Following the already completed CEIV Pharma certification by IATA, GEODIS’ ocean freight service in Hamburg has now successfully achieved GDP (Good Distribution Practice) compliance through Bureau Veritas.
Nigel Winteringham, director, strategic sales, life sciences, EMEA & APAC, Loftware discusses how in today’s business landscape, an organisation’s environmental footprint is something that must be a priority.
Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate personalised treatment for patients.
Tillotts Pharma ("Tillotts") marks its 15th anniversary as a member of the Japanese Zeria Group, celebrating a period of growth and collaboration together.
JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform.
Rachel Reeves is right: the UK is at the forefront of life sciences, with some world-leading research and innovation. But there’s a big hole in the plan the chancellor outlined in her big growth speech yesterday.
UPS Healthcare has opened three new specialised cross-docking facilities in Milan, Frankfurt and Mexico City. These facilities provide support for pharmaceutical shipments with a range of time and temperature control requirements.
